INTRODUCTION
Although much has been learned about the induction of carcinogenesis from in vitro and in vivo studies of "low" dose high LET radiation, recent attempts to refine biophysical models of carcinogenesis have resulted in calls for more information. In particular Brenner and Hall who have been attempting to explain the inverse dose rate effect, which includes a sensitive window hypothesis, have concluded that all the models cannot be tested adequately below 10 cGy or so 1) . They attribute this problem to a lack of data below 10 cGy and also, the lack of mechanistic data to test the hypothesis of cell cycle dependence. In a work shop summary from a meeting organized by Dr. Elkind in 1990 similar calls for more careful studies at "biologically significant low doses" were made (Elkind personnel communication). In particular, due to a lack of statistically significant data on carcinogenic endpoints at doses below 10 cGy and going down to doses below 1 cGy, it is still not clear if a linear no threshold model is correct at all dose levels, no matter how low the dose.
In 1984, we published a study in which we stated that the "presumed" process by which an "inverse dose rate" effect was observed for fission neutrons appeared to require no more than 40 minutes to occur 2) . This was deduced from a study where a single dose was given at different dose rates. The resulting transformation frequencies showed the inverse dose rate effect appearing as dose rate fell below 5 cGy/min and nearly reaching its maximum value when 0.1 cGy/min was given.
Two years later (1986) Rossi and Kellerer published a paper suggesting that a "window of sensitivity" may occur for radiation induced neoplastic transformation that might help to explain the so called "anomalous results" 3) . Subsequently, both Elkind, and Brenner and Hall have sought to formalize Rossi's idea and have developed models that assume there is a window of sensitivity in the cell cycle. In part these efforts were driven by some of the reports in the literature that conflicted with or disputed the original reports by our laboratories.
In 1988 and again in 1991 Balcer-Kubicek and Harrison et al, reported that they could find no dose rate effect using C3H10T1/2 cells and fission neutrons from the Triga reactor at AFFRI 4) . In 1987 Hieber et al reported that they also saw no dose rate effect for treatment of 10T1/2 cells with alpha-particles 5) .
However, during the same period we reported that the effect was evident and appeared to have an energy dependence when several fast neutron beams were examined 6) . We also showed that fractionated fission neutron exposures can produce an enhanced effect compared to single doses. In this study we gave fractions once a day for five days. Also Jones et al 7) and Redpath et al 8) reported that the inverse dose rate effect was also observed in Syrian Hamster cells and Hela/ human hybrid cell transformation assays respectively. Both studies used fission neutrons. In the Redpath studies, neutrons at both the Argonne reactor and the Triga reactor at AFFRI gave similar results. This was in contradiction to the data from Balcer-Kubicek et al who also used the TRIGA reactor.
These apparent discrepancies began to make some scientific sense with the reports and subsequent publication by Miller et al in 1990 and 1991 9) , first showing a mono-energetic neutron energy dependence for the inverse dose rate effect and more recently an LET dependence for charged particles. These studies show that the energy or LET of the radiation is quite critical. Inverse dose rate effects seem to peak at about 5.9 MeV for mono-energetic neutrons and at about 100 KeV per micron for charged particles. In both cases Miller et al report the effect falls of rapidly on either side. From these results it appears clear that Hieber's earlier study was at an LET where little effect should be observed.
Between 1992 and 1995, Bettega et al 10) showed some enhancement for 4.3 MeV alpha particles using the 10T1/2 cells assay, while Saran et al 11) in Italy, did not show any effect using fission neutrons in the same assay. Wargul et al 12) reported an enhancement of cataract formation by dose fractionation, a result which agreed with a study by Yang et al 13) that had reported enhancements using protracted heavy ions in 1987. There have also been several reports that inverse dose rate effects can be observed in mutation assays, although there is not room here to go into that aspect. With the introduction of his model in 1991, Elkind also provided explanations consistent with the model for the absence of inverse dose-rate effects in some reports. In some instances this was thought to be due to the protracted doses being too short or the inter-fraction interval too short. In others, Elkind suggested rounded-up mitotic cells were accidentally lost from the population exposed. Subsequently Dr. Brenner presented a model, also suggesting that the dose rate or fractionation protocol was critical and that some studies had chosen schedules that would not result in an inverse dose rate effect.
When all the cell data and the animal data (from studies in the late 70's and up to mid 80's) are taken together it is clear that the inverse dose rate effect does occur, that it is tissue specific, energy or LET dependent and dependent on the dose protraction schedule used. It is thus likely that some studies will observe the effect and some will not. Both Brenner and Elkind assert that the main reason for sensitivity is that there are one or more windows of sensitivity in the cell cycle. Cao et al 14) from Elkind's group have shown that 10T1/2 cells synchronized by mitotic shake-off are indeed more sensitive to X-ray exposure in late G2 or Mitosis. In a similar study Miller et al 15) showed preliminary data for X-rays suggesting two sensitive windows, namely G2/ M and G1/S borders and later published a report of neutron exposures on synchronized cells. In experiments we were not able to complete due to the closing of the Janus reactor at Argonne National Laboratory, we also saw strong indications of a cell cycle effect on transformation in C3H10T1/2 cells after fission neutrons. Although data appears to support the notion that the cell has a sensitive window for transforming damage none of the studies we have cited so far have addressed the molecular mechanisms underlying this sensitivity. This question of what exactly are the genes that when damaged by radiation lead to the transformed state has proved particularly intractable. For example Borek made an extensive analysis of X-ray transformed foci using most of the known oncogenes and concluded that none were causative. In fact she showed that X-rays induced unique transforming genes, although these have yet to be identified 16) . Several studies have been completed looking for changes in expression of oncogene proteins or RNA species with the hope that this would lead to a mutated oncogene. For example Leuthauser et al 17) recently reported that they saw increased expression of myc and raf in X-ray transformed 10T1/2 cells but could not definitively pin these changes to a mutation in a known oncogene. They, like Borek, concluded that there is at least one unique transforming gene in this cell line. Previously it has also been reported (Thomas and Guernsey) that a mutated H-ras allele was found in a UV transformed 10T1/2 foci 18) . Furthermore, this led them to speculate that there may be more than one radiation induced transforming gene. There have been several other reports of changes in expression level of one or more oncogenes in cells from radiation induced tumors. But again, most of these have failed to show a mutation in the oncogenes that could be attributed to the radiation exposure. One notable exception was the much earlier report by Guerrero from Pellicer's group that showed a mutation in a c-K-ras oncogene in a mouse lymphoma induced by gamma rays 19) . All this inconclusive evidence led us and others to the hypothesis that recessively acting genes like tumor suppressors are also involved in radiation induced transformation, a point dwelt upon by Cox in a recent review of radiation oncogenesis 20) , and in all likelihood there are at least several unknown genes involved in radiation induced oncogenesis. Since there are no studies specifically addressing the role of radiation quality in the type of gene involved this will also be an important area for further investigation because high LET radiation is so much more effective than gamma rays at producing transformed foci and tumors.
MATERIALS AND METHODS

Transformation assay for C3H10T1/2 cells
Transformation experiments are carried out using a line of mouse embryo derived cells, designated C3H/10T1/2, clone 8. This cell line was developed by Reznikoff and co-workers, (1973) and has been successfully used in in-vitro studies of neoplastic transformation by chemical carcinogens and by ionizing radiation.
Cells are routinely grown in Eagle's Basal Medium enriched with 10% heat-inactivated fetal calf serum (BME-10) at 37°C in humid atmosphere containing 2% carbon dioxide and are passaged once per week. For transformation experiments, cultures between the 8th and 15th passage are used.
A typical experiment in the study of neoplastic transformation with 10T1/2 cells involved 5 to 7 weeks of incubation after the completion of the treatment to induce transformation, with weekly refeeding. At the end of the incubation period, plates or T/75 flasks are stained and scored for colonies of typical morphology that grow on top of the confluent monolayer of normal, contact-inhibited cells. The tumorigenicity of cells isolated from transformed colonies induced by ionizing radiation and identified as type II or III foci has been tested by us and others.
For transformation assays, cells are grown in large plastic petri dishes (100 mm) or T/75 flasks. Cultures are incubated long enough before the start of irradiations to re-establish active growth, so that experiments can performed with actively growing cultures. As described in our previous work 2, [6] [7] [8] , immediately after treatment, suspensions of cells are prepared by trypsinization, and after appropriate dilutions are made, cells are plated from the same suspension for the determination of neoplastic transformation and survival. Cell inocula not exceeding 350 viable cells per 100 mm dish or 600 cells per T/75 flask are used since maximum transformation frequencies are independent of cell density when 20-350 viable cells per dish are plated. For survival measurements, dilutions are adjusted to yield between 50 and 80 colonies per 100 mm dish.
As noted, 5 to 7 re-feedings are required before a culture of cells in a particular dish is ready for staining and scoring of transformed colonies. In recent studies in our laboratories and those of others (M. M. Elkind and J. Bertram, personnel communications), we have switched the culture conditions from 10% to 5% serum in the weekly re-feedings beginning with the 3rd re-feeding. This coincides with cells reaching confluence. It appears that with this schedule, transformed cells produce more defined foci and the confluent background of non-transformed cells form a continuous lawn without holes or "patches" as often occurred with refeeedings using the higher percentage of fetal calf serum in the medium.
METHODS FOR RAPD ANALYSIS
Clonal Cell Lysates from Cells in Culture
10 cells per well were aliquoted into 24-well plates. We had determined that on average 3 cells per well give rise to a colony (30% cloning efficiency). Wells were checked for single colonies to be used for the analysis. The number of cells in each colony was estimated from the diameter of the colony. The media was removed and the colony was rinsed with PBS. 100 ml of lysis solution containing 1 mg/ml proteinase K (PK) was added to the well and the resulting cell suspension was heated at 56°C for 30 min. The PK was inactivated with heating at 94°C for 5 min. Lysates were frozen at -70°C until the RAPD analysis could be performed.
Clonal Lysates from Fixed and Stained Colonies on Plates
A small drop of sterile PBS was added to the colony of interest. The colony was scraped into the PBS with a sterile scalpel and the cells were removed to a 1.5 ml eppendorf tube with a sterile pipette tip. The cells were then lysed as described above.
RAPD-PCR
Cell lysates were first diluted 1:5 in sterile water to decrease the concentration of EDTA in the samples. We found this simple dilution step insured the efficiency and reproducibility of the PCR analysis. 2 ml of the diluted lysate was added to 48 ml of PCR reaction mix containing 0.36 mM RAPD-primer, 0.2 mM dNTPs, 2.5 mM MgCl 2 , 20mM Tris-HCl, pH 8.4, 50 mM KCl and 1.5 U Taq (Life Technologies). The samples were overlaid with mineral oil and cycled at 94°C, 30 sec, 36°C, 30 sec, 72°C, 2 min for 45 cycles. 10 ml of the amplified product was then electrophoresed through a 1.5% agarose gel and visualized by ethidium bromide staining.
RESULTS AND DISCUSSION
There remain several vexing questions about the effectiveness of neutrons in the low dose region of exposure and about the shape of the dose response. The role of repair although at first thought to be unimportant cannot be ignored because repair mechanisms are now known to excise large and bulky lesions. Then there is the question of susceptibility to cancer induction by radiation if a person is a carrier of one or more tumor suppressor gene mutations. Their role in low dose sensitivity is so far unknown. However this fraction of the population, which may amount to as much as 15% might very well be contributing a significant number of the excess cancers due to radiation. That is, they may be much more sensitive to radiation-induced cancer than the normal population. To address these questions, earlier data needs to be reexamined and new ideas need to be tested.
In all the studies we have cited there is only one that uses doses below 10 cGy at high or low dose rate [Hill et al 21) ]. In Fig. 1 we have reproduced the data from the paper in simplified form.
It is very clear in this data from a study with C3H10T1/2 cells that a linear response even at low doses is the best fit to the data. It is also clear that low dose rate has a much bigger effect than high dose rate in these cells for the fission spectrum neutrons used. The smallest dose in this study was 2.3 cGy. There are no studies of carcinogenesis below this dose or below 10 cGy for high dose rate. To examine the 0.0 to 10 cGy region of dose, new methods for detecting the transformed, malignant or genetically damaged cell are needed such that millions of cells can be screened quickly, accurately and cheaply. Undoubtedly new technology and new molecular discoveries will soon make this goal achievable. Before we introduce one such idea let us examine for a moment the role repair might have in the carcinogenic frequency after a radiation exposure. We and others have shown that at least some repair does occur after DNA is damaged by neutrons. For example in a study published in 1989 we showed that about 70% of double strand breaks can be repaired after exposure to fission neutron radiation compared to 98% for gamma rays 22 ) (see Fig. 2 for details of the experimental data). However the neutral elution assay only measures rejoining and does not give any indication of the fidelity of the repair. The data do clearly demonstrate however that repair of some form does occur after exposure of cells to high LET radiation.
In the C3H10T1/2 cell transformation assay the cells are already changed from the animal tissue state in that they grow indefinitely in cell culture dishes, are hypotetraploid and continue to progrees towards a transformed state if cultured for long periods of time. One might say they are the equivalent of a cell population that has already undergone one of the mutagenic events to cause a malignant change but further hits are required to complete the transformation process. In this assay it only takes about 13 divisions of the cells (or about 6 weeks) after irradiation to get expression of the malignant phenotype in some cells that then give rise to malignant foci. This seems inordinately short compared to the long lag times in the majority of animal and human populations that have been exposed. However in animal studies, all the animals are usually isogenic, that is coming from inbred stock. In humans this is not the case. Indeed, it now appears that human genetic diversity includes a small but significant (up to about 15%) part of the population who may carry some form of susceptibility gene for cancer induction. There is epidemiological evidence that such groups show early onset cancer for some forms of cancer. These people, if you will, already have one lesion and radiation may add the second and causative lesion thus leading to an acceleration of the onset of cancer. We feel that neoplastic transformation in C3H10T1/2 cells may approximate this type of mechanistic response in humans.
RAPD Analysis as an Indicator for Genomic Instability in the Transformation Process
Random amplified polymorphic DNA polymerase chain reaction (RAPD PCR) was developed to detect DNA variations primarily to generate genetic markers for genome mapping. Prior knowledge of the DNA sequence amplified is not needed and by designing a large number of primers of the same length and GC content, a single PCR protocol can be used to quickly screen and detect many DNA variations. Because previous approaches to detecting genes involved in the transformation have been equivocal, we reasoned that the RAPD approach may be useful for detecting DNA variations among transformed clones of C3H10T1/2 cells and hence may be able to detect the radiation induced damage. Since radiation produces damage in many cells and the damage is apparently random in its location, we also reasoned that RAPD primers might be used to develop a quantitative measure of the residual damage in a cell after its exposure is complete. This residual damage, be it a point mutation, a deletion, rearrangement or a recombination event should alter the DNA sequence from that of the original untreated cell, and thus alter the DNA fingerprint given by RAPD analysis. The technique uses a single primer of arbitrary nucleotide sequence to amplify DNA. When two complementary sites for the primer exist in the correct orientation to each other, a PCR product/s is/are produced. DNA fragments are easily visualized on an agarose gel and DNA variations between clones can be analyzed. We have taken this approach to compare RAPD generated DNA fragments between C3H10T1/2 transformed clones as well as untreated control colonies. The chemical reaction conditions were carefully determined to optimize the PCR reaction for maximum consistency using several RAPD primers. Our preliminary data using this approach has shown that Type II and III transformed clones have clearly different RAPD patterns compared to their parent cells while Type I clones have patterns similar to the parent clones. Type II and III foci are considered to be farther along in the tumorigenic process than Type I clones. Type II and III clones typically can generate tumors in nude mice with high efficiency. In Fig. 3 data for three mouse strains and for C3H10T1/2 cells demonstrate the principal that single RAPDs can show unique band patterns that are generated by the changes in DNA sequence as a result of irradiation and repair of damaged DNA. Lanes 3 and 4 are Balb/c and SJL mouse DNA respectively, lane 5 is DNA from a Type III transformed clone of C3H10T1/2 cells and lanes 6 and 7 are untreated C3H10T1/2 cells from passages 11 and 14 respectively. In this case the transformed clone was isolated from cells that had received 150 cGy of Gamma rays given at a dose rate of 10 cGy per day, a chronic low dose rate schedule. In Fig.  4 we show the same set of samples for two different RAPDs. In this case RAPD 82 happens to have only one clearly obvious band for all three mouse strains. However, in the transformed cell there are at least 8 clear bands. We believe it may be possible to use the change in number of bands to estimate the frequency of heritable residual damage in the genome of somatic cells after a given dose of radiation or other DNA damaging agent. In both cases we obtained unique and identical patterns for the control cells which appear to be stable in culture. These stable patterns (no changes observed for 4 different RAPD primers between passage 7 and 14) allow one a high degree of confidence that the patterns obtained for treated cells are indeed due to the processing of radiation-induced damage. One possible use of such a panel of RAPD primers is to identify unique patterns in transformed cells that can then be used as a starting point for tracing the exact part of the genome that has become permanently altered in the cell. In the last Figure (Fig. 5) , we show the RAPD patterns for a series of transformed clones derived from various radiation treatments. Some clones show changes in band patterns for one or more of the three RAPD primers chosen and some do not. Based on our observations so far and on the work of others we expect that a unique pattern of RAPD changes can be obtained for every distinct unique clone if about 15 distinct RAPD primers are used to analyze each clone. Undoubtedly there will be other new methods for analyzing DNA damage induced by small doses of radiation. However to achieve the level of sensitivity required to estimate the long term effects of very small chronic doses, we think that methods such as described above have the most potential because they are non-specific and scan for damage genome-wide. They also only detect damage that has become fixed in the genome and has the potential to be passed from one cell generation to another. Our hope is that such methods will become powerful tools in the search for the precise quantitative analysis of the damage produced by very small doses of High LET radiation, and in determining the long term consequences of that damage.
